Search

everythinglearnresearchcommunity

for

Search:↓

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

A genetic marker linked to a type of hair loss was found in most patients studied.

Frontal fibrosing alopecia has occurred in two related male families.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

FFA's causes may include environmental triggers and genetic factors.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Frontal Fibrosing Alopecia might be an autoimmune disease.